Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

7.50
+0.04000.54%
Volume:111.36K
Turnover:848.79K
Market Cap:160.33M
PE:-1.74
High:7.81
Open:7.42
Low:7.42
Close:7.46
52wk High:13.37
52wk Low:4.09
Shares:21.38M
Float Shares:14.25M
Volume Ratio:0.59
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3219
EPS(LYR):-5.4849
ROE:-80.64%
ROA:-17.29%
PB:2.02
PE(LYR):-1.37

Loading ...

Enanta Pharmaceuticals (ENTA) Receives a Buy from Evercore ISI

TIPRANKS
·
Yesterday

Enanta Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Sep 15

Enanta Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Officer Kathleen S. Capps

Reuters
·
Sep 09

Enanta Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Harry R. Trout III, Vice President, Finance

Reuters
·
Sep 09

Enanta Pharmaceuticals Chief Financial, Administrative Officer Dies

MT Newswires Live
·
Sep 03

Enanta Pharmaceuticals Chief Financial Officer Paul Mellett Dies

Dow Jones
·
Sep 03

Enanta Pharmaceuticals Appoints Interim Financial and Accounting Officers Following the Passing of CFO Paul J. Mellett Jr

Reuters
·
Sep 03

Enanta Pharmaceuticals Announces the Passing of Its Beloved and Respected Longtime Chief Financial and Administrative Officer Paul J. Mellett Jr.

THOMSON REUTERS
·
Sep 03

Enanta Pharmaceuticals Initiated at Buy by WestPark Capital

Dow Jones
·
Sep 02

BRIEF-Enanta Pharmaceuticals Appoints Harry R. Trout As Interim Principal Financial Officer

Reuters
·
Aug 28

Enanta Pharmaceuticals - Appoints Harry R. Trout as Interim Principal Financial Officer - SEC Filing

THOMSON REUTERS
·
Aug 28

Enanta Pharmaceuticals Appoints Interim Financial Officers During Chief Financial and Administrative Officer's Medical Leave

Reuters
·
Aug 28

Enanta Pharmaceuticals to Participate in Upcoming September Investor Conferences

Reuters
·
Aug 21

Enanta Pharmaceuticals Files European Patent Infringement Suit Against Pfizer Over COVID-19 Antiviral

Reuters
·
Aug 20

Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union

THOMSON REUTERS
·
Aug 20

Enanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 12

Enanta Pharmaceuticals Reports Q3 Net Loss of $18.3M, EPS Improves to $0.85 Loss Compared to $1.07 Loss in 2024; Revenue Slightly Up at $18.3M

Reuters
·
Aug 12

BRIEF-Enanta Pharmaceuticals Q3 Revenue USD 18.314 Million

Reuters
·
Aug 12

Enanta Pharmaceuticals Q3 EPS USD -0.85

THOMSON REUTERS
·
Aug 12

Enanta Pharmaceuticals Inc expected to post a loss of $1.28 a share - Earnings Preview

Reuters
·
Aug 09